The identification of distinct roles for the two pITIMs of IDO1 may pave the way to innovative strategies in treating autoimmune, chronic inflammatory and neoplastic diseases by either enhancing or terminating IDO1's activity, as appropriate. The gene discussed is IDO1; the disease is neoplasm.